Mark Rasenick Email

President, Chief Scientific Officer and Founder . PAX Neuroscience

Current Roles

Employees:
7
Revenue:
$1.1M
About
The WHO estimates that by 2020, depression will be the leading cause of disability worldwide. Pax Neuroscience, Inc. is a clinical diagnostics company focused on development and commercialization of blood tests for depression diagnosis and for antidepressant response. These tests are based on novel protein biomarkers derived from hypothesis-driven data sets and early clinical results are promising.
PAX Neuroscience Address

null, null
United States
PAX Neuroscience Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.